Anti-Hu CD34 FITC

*Elknerová K, Lacinová Z, Soucek J, Marinov I, Stöckbauer P: Growth inhibitory effect of the antibody to hematopoietic stem cell antigen CD34 in leukemic cell lines. Neoplasma. 2007;54 (4) :311-20., URL: http://www.ncbi.nlm.nih.gov/pubmed/17822321?itool=

*Krauter J, Hartl M, Hambach L, Kohlenberg A, Gunsilius E, Ganser A, Heil G: Receptor-mediated endocytosis of CD34 on hematopoietic cells after stimulation with the monoclonal antibody anti-HPCA-1. J Hematother Stem Cell Res. 2001 Dec;10 (6) :863-71., URL: http://www.ncbi.nlm.nih.gov/pubmed/11798512?ordina, *Dao MA, Arevalo J, Nolta JA: Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood. 2003 Jan 1;101 (1) :112-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/12393633?ordina, *Gangenahalli GU, Singh VK, Verma YK, Gupta P, Sharma RK, Chandra R, Gulati S, Luthra PM: Three-dimensional structure prediction of the interaction of CD34 with the SH3 domain of Crk-L. Stem Cells Dev. 2005 Oct;14 (5) :470-7., URL: http://www.ncbi.nlm.nih.gov/pubmed/16305332?ordina, *Gangenahalli GU, Singh VK, Verma YK, Gupta P, Sharma RK, Chandra R, Luthra PM: Hematopoietic stem cell antigen CD34: role in adhesion or homing. Stem Cells Dev. 2006 Jun;15 (3) :305-13., URL: http://www.ncbi.nlm.nih.gov/pubmed/16846369?ordina